AUG 07, 2018 08:50 PM PDT

Improving Liver Cancer Therapy

WRITTEN BY: Nouran Amin

According to studies conducted in the United States, the ninth leading causes of cancer deaths is hepatocellular carcinoma, the primary cancer of the liver. Hepatocellular carcinoma tends to grow and expand at an increasingly fast rate and if not diagnosed early on then affected individuals may not always survive longer than 11 months. Specialists seek to treat their patients by usually prescribing a therapeutic drug known as "sorafenib." However, the drug will typically prolong the survival of individuals by only 3 months, and it can bring numerous negative side-effects.

Watch Alternative Treatment Options:

To seek other options in an effort to improve liver cancer treatment, cancer researchers from multiple international institutions have collaborated together to treat a therapeutic drug that holds high efficacy for the treatment of liver cancer. The compound was developed primarily by researchers from the Cancer Institute of Singapore at the National University of Singapore in Queenstown along with colleagues from other global institutions.

The new experimental drug, which researchers refer to as "FFW", holds the potential to treat liver cancer by improving survival rates and lessening adverse effects additionally it is believed to alter the growth of primary liver cancer and help reduce the unwanted effects of typical therapy. In the journal PNAS, the development of FFW is outlined by the researchers in the most recent publication. "In our latest work, [we have] demonstrated an effective strategy to accurately target oncogenes previously considered undruggable," says study co-author and professor at the National University of Singapore, Daniel Tenen.

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 16, 2018
Drug Discovery
OCT 16, 2018
Potential Targeted Treatment for Crohn Disease
Emerging as a global disease with rates increasing the past 5 decades, Crohn’s disease (CD) is the chronic inflammation of the intestinal tract. Now,...
OCT 30, 2018
Drug Discovery
OCT 30, 2018
Combination of Drugs Extends Lifespan of C. elegans
In a study published in the journal Developmental Cell, a cocktail of pharmaceutical drugs were recently found to extend the life of the microscopic worm,...
DEC 20, 2018
Health & Medicine
DEC 20, 2018
Common Medication Regimens for Sarcoidosis
Sarcoidosis is a granulomatous disease that most commonly affects the lungs, but any organ system can be involved. It is most often found and diagnosed in...
DEC 19, 2018
Drug Discovery
DEC 19, 2018
Promising Drug for ALS?
ALS, standing for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease, is a progressive neurodegenerative disease affecting the nerve cel...
FEB 01, 2019
Drug Discovery
FEB 01, 2019
Statin Therapy Reduces Risk of Cardiovascular Complications Regardless of Age
A meta-analysis study, from randomized clinical trials, found that regardless of age, statin therapy is effective in decreasing the risk of developing vasc...
FEB 01, 2019
Drug Discovery
FEB 01, 2019
Re-purposing Anti-rejection Drug for Liver Cancers
Scientists at the University of Pittsburgh School of Medicine have identified a molecular pathway in liver that can allow an anti-rejection drug to be repu...
Loading Comments...